Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Oncology, Cancer, Breast cancer, Head and neck cancer, and Head and neck.
Update Breast Cancer 2024 Part 3 – Patients with Advanced Stage Breast Cancer
Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer
Overall survival in patients with <i>BRCA</i>-mutated platinum-sensitive relapsed ovarian cancer (PSROC) treated with olaparib maintenance: Real-world data of the C-PATROL study.
802P Real-world data of olaparib maintenance therapy in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer: Final results of the C-PATROL study
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
Correction: Update Breast Cancer 2021 Part 5 – Advanced Breast Cancer
First‐line therapy with bendamustine/prednisone/bortezomib—A GMMG trial for non‐transplant eligible symptomatic multiple myeloma patients
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
Update Mammakarzinom 2020 Teil 1 – frühes Mammakarzinom: Konsolidierung des Wissens über bekannte Therapien
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
Primary results from EMILIA, a phase III study of trastuzumab emtansine (T-DM1) versus capecitabine (X) and lapatinib (L) in HER2-positive locally advanced or metastatic breast cancer (MBC) previously treated with trastuzumab (T) and a taxane.